Answers are grounded in this paper and cite their sources.
Background : Managing fine motor impairments in Parkinson's disease (PD) remains a clinical challenge, particularly because of the incomplete understanding of how sensory feedback, hand dominance, and patient-specific factors modulate grip force and tremor. Methods : This cross-sectional secondary analysis of baseline data from a randomized controlled trial involved 26 individuals diagnosed with PD who performed isometric grip tasks under visual feedback (VF) and no-feedback (NFB) conditions. Grip force and tremor dynamics were quantified using time-domain analysis and advanced wavelet-based techniques. The primary outcomes included maximum voluntary contraction (MVC), force variability, tremor amplitude, and coherence between the force and tremor signals. Findings : Visual feedback significantly modulated tremor amplitude and force variability, with pronounced effects in participants with moderate PD severity. In individuals with mild PD, grip force showed a marked age-related decline, predominantly in the non-dominant hand, and asymmetry diminished with increasing disease severity. Exploratory sex-related patterns were observed, including differences in tremor measures across severity strata; however, these findings are highly suggestive but not yet generalizable, given the marked subgroup imbalance, particularly the presence of only one woman in the moderate PD group. Wavelet analyses identified low-frequency oscillations (0–1 Hz) as crucial differentiators of motor impairment levels, revealing enhanced coherence between force and tremor signals in the absence of visual feedback. Interpretation : These findings support the potential value of wavelet-based assessments in quantifying motor deficits in patients with PD. These findings may help inform future studies and rehabilitation strategies that consider sensory feedback, hand dominance, and patient characteristics. Trial Registration : This study is a secondary analysis of baseline data from a randomized controlled trial registered in the Brazilian Clinical Trials Registry (ReBEC; registration number RBR-2jyc55x).
No takes yet. Share an insight, caveat, or question.
Neto et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: